Our Facilities
Overview
Our brand-new state-of-the-art current Good Manufacturing Practice (cGMP) facilities follow international standards specific for the complex manufacturing process of advanced therapy medicinal products to ensure quality, safety, and efficacy.
- State-of-the-art commercial cGMP facilities for cell and gene therapy products.
- Designed to be compliant with United States Food and Drug Administration (USFDA), European Medicines Agency (EMA), and Pharmaceutical Inspection Co-operation Scheme (PIC/S) for early phase clinical trial materials in the cell and gene therapy markets.
